-
-
-
Uxin Announces Entry into Definitive Agreements for Financing
BEIJING,March 5,2025-- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China\'s leading used car retailer,today announced that,it entered into certain definitive agreements w
-
-
-
-
This is Wuhan: a journey through time
WUHAN,China,March 5,2025-- A report fromChangjiang Daily. This is Wuhan: a journey through time Recently,"Traveling in China" has become a highly trending topic on social media platforms,as
-
-
-
-
Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma
HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria
-
-
-
-
USHOPAL Expands Global Luxury Beauty Portfolio with the Acquisition of French Skincare Icon PAYOT
SHANGHAI,March 4,2025-- USHOPAL Group continues to solidify its position as the first China-based luxury beauty group to emerge on the global stage,with an acquisition strategy that focuses on strong
USHOPAL Group / 03-06
-
-
-
-
GTS Techlabs and Peacom Announce Strategic Partnership to Transform Business Messaging at MWC Barcelona 2025
BARCELONA,Spain,March 5,2025-- GTS Techlabs,the technology arm ofGlobe Teleservices (GTS),a leading telecom solutioncompany,and Peacom have announced a strategic partnership at Mobile World Congress
Globe Teleservices / 03-06
-
-
-
-
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024
Prenetics / 03-06
-
-
-
-
Global Industry Partners Jointly Release Net5.5G Best Practices & Deployment Guide Whitepaper
BARCELONA,Spain,March 5,2025-- At MWC Barcelona 2025,the Broadband Development Congress (BDC),hosted by the WBBA,was a resounding success. Themed "Smarter Broadband: Investment. Innovation. Intel
Huawei / 03-06
-
-
-
-
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL
PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.
CStone Pharmaceuticals / 03-06
-
-
-
-
Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma
HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria
Akeso, Inc. / 03-06
-
-
-
-
A New University Science Park of Neusoft Institute Guangdong to Foster Innovation in Cross-sector Development
HONG KONG,March 1,2025-- Neusoft Institute Guangdong,a member of Neutech Group Limited,has successfully acquired the land use rights for a new 140,000-square-meter plot in Nanhai District,Foshan City,
-
Finance
Newest
